[1]
Carpenter, B.P. et al. 2016. Identification of Factors Impacting Recurrent Clostridium difficile Infection and Development of a Risk Evaluation Tool. Journal of Pharmacy & Pharmaceutical Sciences. 19, 3 (Sep. 2016), 349–356. DOI:https://doi.org/10.18433/J32S41.